Shaanxi Kanghui Pharmaceutical (603139.SH) plans to change its stock abbreviation to "Kanghui shares".
Kanghui Pharmaceutical (603139.SH) announced that, according to the company's long-term development plan, the company plans to change its stock abbreviation from "..."
Shaanxi Kanghui Pharmaceutical (603139.SH) has announced that, in accordance with the company's long-term development plan, it plans to change its stock abbreviation from "Shaanxi Kanghui Pharmaceutical" to "Kanghui Pharmaceuticals". The new stock abbreviation is concise and clear, retaining the core brand identity of "Kanghui" while also adding the word "Pharmaceuticals", which will help the market better understand the company's development positioning and enable investors to accurately grasp the company's core values and development direction.
Related Articles
GRAND FIELD GP(00115) issued 8.4615 million new shares due to the convertible bond being converted.
CHINA ENV RES (01130) issued a profit warning, expecting the annual comprehensive loss to decrease by no less than 35% year-on-year.
IGG (00799) spent HKD 533,400 to repurchase 120,000 shares on September 16th.
GRAND FIELD GP(00115) issued 8.4615 million new shares due to the convertible bond being converted.
CHINA ENV RES (01130) issued a profit warning, expecting the annual comprehensive loss to decrease by no less than 35% year-on-year.
IGG (00799) spent HKD 533,400 to repurchase 120,000 shares on September 16th.
